v3.25.4
Earnings Per Share
 12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
AbbVie grants certain restricted stock units (RSUs) that are considered to be participating securities. Due to the presence of participating securities, AbbVie calculates earnings per share (EPS) using the more dilutive of the treasury stock or the two-class method. For all periods presented, the two-class method was more dilutive.
The following table summarizes the impact of the two-class method:
Years ended December 31,
(in millions, except per share data)202520242023
Basic EPS
Net earnings attributable to AbbVie Inc.$4,226 $4,278 $4,863 
Earnings allocated to participating securities40 40 43 
Earnings available to common shareholders$4,186 $4,238 $4,820 
Weighted average basic shares of common stock outstanding1,769 1,769 1,768 
Basic earnings per share attributable to AbbVie Inc.$2.37 $2.40 $2.73 
Diluted EPS
Net earnings attributable to AbbVie Inc.$4,226 $4,278 $4,863 
Earnings allocated to participating securities40 40 43 
Earnings available to common shareholders$4,186 $4,238 $4,820 
Weighted average shares of common stock outstanding1,769 1,769 1,768 
Effect of dilutive securities4 4 5 
Weighted average diluted shares of common stock outstanding1,773 1,773 1,773 
Diluted earnings per share attributable to AbbVie Inc.$2.36 $2.39 $2.72 
Certain shares issuable under stock-based compensation plans were excluded from the computation of EPS because the effect would have been antidilutive. The number of common shares excluded was insignificant for all periods presented.